Shares in South African drugmaker Adcock Ingram surge more than 2% to R66.35 after it flagged a rise of up to 24.8% in full-year earnings it reported on Tuesday . The drugmaker said it expects headline earnings per share (EPS) to rise to between 380 and 390 cents in the year ended June 30, 2018, from 312.6 cents a year earlier. Headline EPS is the main profit measure in South Africa that strips out certain one-off items. 